Show simple item record

dc.contributor.authorSaunders, Philippa M.*
dc.contributor.authorPymm, Phillip*
dc.contributor.authorPietra, Gabriella*
dc.contributor.authorHughes, Victoria A.*
dc.contributor.authorHitchen, Corinne*
dc.contributor.authorO'Connor, Geraldine M.*
dc.contributor.authorLoiacono, Fabrizio*
dc.contributor.authorWidjaja, Jacqueline M.*
dc.contributor.authorPrice, David A.*
dc.contributor.authorFalco, Michela*
dc.contributor.authorMingari, Maria C.*
dc.contributor.authorMoretta, Lorenzo*
dc.contributor.authorMcVicar, Daniel W.*
dc.contributor.authorRossjohn, Jamie*
dc.contributor.authorBrooks, Andrew G.*
dc.contributor.authorVivian, Julian P.*
dc.date.accessioned2016-04-20T10:47:57Z
dc.date.available2016-04-20T10:47:57Z
dc.date.issued2016-04-04
dc.identifier.citationSaunders, P. M., Pymm, P., Pietra, G., Hughes, V. A., Hitchen, C., O'Connor, G. M., Loiacono, F., Widjaja, J., Price, D. A., Falco, M., Mingari, M. C., Moretta, L., McVicar, D. W., Rossjohn, J., Brooks, A. G., & Vivian, J. P. (2016). Killer cell Immunoglobulin-like Receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. Journal of Experimental Medicine. http://dx.doi.org/10.1084/jem.20152023
dc.identifier.issn0022-1007en
dc.identifier.doi10.1084/jem.20152023
dc.identifier.urihttp://hdl.handle.net/10034/606045
dc.descriptionThis is the authors accepted manuscript.
dc.description.abstractNK cells play a key role in immunity, but how HLA-I and KIR3DL1 polymorphism impacts on disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognising the widest array of HLA-I ligands. These differences were further reflected in unctional studies utilising NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005 and *015 polymorphisms are remote from the KIR3DL1-HLA-I interface, the structures of these three KIR3DL1-HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs.
dc.language.isoen_USen
dc.publisherRockefeller University Press
dc.relation.urlhttp://jem.rupress.org/content/early/2016/03/29/jem.20152023.abstracten
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectNatural Killer Cellsen
dc.subjectKIRen
dc.titleKiller cell Immunoglobulin-like Receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognitionen_US
dc.typeArticle
dc.identifier.eissn1540-9538
dc.contributor.departmentDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia; Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia; Department of Experimental Medicine, University of Genova, Genoa, 16132 Italy; IRCCS AOU San Martino-IST (National Institute for Cancer Research), Genoa, 16132 Italy; IRCCS Istituto Giannina Gaslini, Genoa, Italy; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; IRCCS Ospedale Pediatrico Bambino Gesù, Roma ITALY; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD 21702, USA
dc.identifier.journalJournal of Experimental Medicineen
dc.date.accepted2016-03-15
or.grant.openaccessYesen
rioxxterms.funderNational Health and Medical Research Council (Australia); Worldwide cancer research organisation; The Intramural program of the National Cancer Institute; Wellcome Trusten
rioxxterms.identifier.projectExternally Funded - not through Chester Universityen
rioxxterms.versionAMen
html.description.abstractNK cells play a key role in immunity, but how HLA-I and KIR3DL1 polymorphism impacts on disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognising the widest array of HLA-I ligands. These differences were further reflected in unctional studies utilising NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005 and *015 polymorphisms are remote from the KIR3DL1-HLA-I interface, the structures of these three KIR3DL1-HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs.


Files in this item

Thumbnail
Name:
SaundersJEM.pdf
Size:
11.17Mb
Format:
PDF
Request:
Main article

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/